Searching for a Cure: The FDA's Regulatory Approach to Traditional Chinese Herbal Medicine

DSpace/Manakin Repository

. . . . . .

Title:	Searching for a Cure: The FDA's Regulatory Approach to Traditional Chinese Herbal Medicine
Author:	Kim, Anna L.
Citation:	Searching for a Cure: The FDA's Regulatory Approach to Traditional Chinese Herbal Medicine (1997 Third Year Paper)
Full Text & Related Files:	akim.pdf (383.7Kb; PDF) akim.rtf (218.4Kb; RTF file) akim.html (158.2Kb; HTML)
Abstract:	I will begin this discussion by describing traditional Chinese medicine and how it compares to the Western medical tradition. Second, I will then examine why regulation is necessary given the impact of Chinese herbal medicine on American healthcare. Then, I will proceed to the problem of trying to fit a square peg into a round hole, namely, the issue of regulating Chinese herbal medicine under current statutory provisions. Fourth, I will analyze state and federal responses to alternative therapies in general and Chinese herbal medicine in particular, afterwards focusing on the FDA's piecemeal approach thus far. Finally, I will examine two potential models for reform, Germany and Canada, to see if there are lessons to be leamed from their practices.
Terms of Use:	This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page:	http://nrs.harvard.edu/urn-3:HUL.InstRepos:9414574